Related Experiment Video
Updated: Feb 26, 2026
08:43
Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
20.5K
Thrombospondins: A Role in Cardiovascular Disease
Dimitry A Chistiakov1, Alexandra A Melnichenko2, Veronika A Myasoedova3
1Department of Fundamental and Applied Neurobiology, Serbsky Federal Medical Research Center of Psychiatry and Narcology, 119991 Moscow, Russia. dimitry.chistiakov@lycos.com.
International Journal of Molecular Sciences
|July 18, 2017
Summary
Thrombospondins (TSPs) are extracellular matrix proteins crucial for cardiovascular health. Activating cardiac TSP signaling may offer therapeutic benefits for cardiovascular diseases like heart failure and myocardial infarction.
Area of Science:
- Cardiovascular Biology
- Extracellular Matrix Research
- Protein Biochemistry
Background:
- Thrombospondins (TSPs) are extracellular matrix proteins with complex structures interacting with various cellular components.
- TSP1, TSP2, and TSP4 are key members influencing cardiac remodeling and ECM composition.
- TSPs play roles in collagen production, growth factor signaling, and cell apoptosis in the heart.
Purpose of the Study:
- To explore the role of TSPs in cardiovascular pathology.
- To evaluate the therapeutic potential of targeting TSPs in cardiovascular diseases.
- To understand the impact of TSP signaling in cardiac stress and overload.
Main Methods:
- Utilized TSP-deficient animal models to study cardiovascular conditions.
- Analyzed the influence of TSPs on cardiac remodeling markers.
- Investigated TSP involvement in myocardial infarction, hypertrophy, and heart failure.
Main Results:
- TSP-deficient models aided in assessing TSP contributions to cardiovascular diseases.
- TSPs were found to influence collagen production, TGF-β signaling, and cardiomyocyte apoptosis.
- Targeting TSPs demonstrated significant therapeutic value in cardiovascular disease models.
Conclusions:
- Cardiac TSP signaling activation may be beneficial under stress and pressure overload.
- Targeting TSPs holds therapeutic promise for treating cardiovascular diseases.
- Understanding TSP functions is vital for developing novel cardiovascular therapies.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
01:16Clot Retraction and Fibrinolysis
9.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.6K
01:30Venous Thrombosis I: Introduction
562
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
562
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.4K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
01:24Disorders of Hemostasis
2.4K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.4K
01:29Venous Thrombosis III: Interprofessional Care
410
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
410